Lluis Puig
Lluis Puig
Department of Dermatology, Hospital de la Santa Creu i Sant Pau
Verified email at santpau.cat
Cited by
Cited by
Secukinumab in plaque psoriasis—results of two phase 3 trials
RG Langley, BE Elewski, M Lebwohl, K Reich, CEM Griffiths, K Papp, ...
New England Journal of Medicine 371 (4), 326-338, 2014
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
IB McInnes, A Kavanaugh, AB Gottlieb, L Puig, P Rahman, C Ritchlin, ...
The Lancet 382 (9894), 780-789, 2013
Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions
BB Davidovici, N Sattar, PC Jörg, L Puig, P Emery, JN Barker, ...
Journal of Investigative Dermatology 130 (7), 1785-1796, 2010
Phase 3 studies comparing brodalumab with ustekinumab in psoriasis
M Lebwohl, B Strober, A Menter, K Gordon, J Weglowska, L Puig, K Papp, ...
New England Journal of Medicine 373 (14), 1318-1328, 2015
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological …
C Ritchlin, P Rahman, A Kavanaugh, IB McInnes, L Puig, S Li, Y Wang, ...
Annals of the rheumatic diseases 73 (6), 990-999, 2014
Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey
MG Lebwohl, H Bachelez, J Barker, G Girolomoni, A Kavanaugh, ...
Journal of the American Academy of Dermatology 70 (5), 871-881. e30, 2014
Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of …
A Kavanaugh, C Ritchlin, P Rahman, L Puig, AB Gottlieb, S Li, Y Wang, ...
Annals of the rheumatic diseases 73 (6), 1000-1006, 2014
Epidemiology of atopic dermatitis in adults: results from an international survey
S Barbarot, S Auziere, A Gadkari, G Girolomoni, L Puig, EL Simpson, ...
Allergy 73 (6), 1284-1293, 2018
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and …
KB Gordon, B Strober, M Lebwohl, M Augustin, A Blauvelt, Y Poulin, ...
The Lancet 392 (10148), 650-661, 2018
Obesity and psoriasis: body weight and body mass index influence the response to biological treatment
L Puig
Journal of the European Academy of Dermatology and Venereology 25 (9), 1007-1011, 2011
Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial
RG Langley, TF Tsai, S Flavin, M Song, B Randazzo, Y Wasfi, J Jiang, ...
British Journal of Dermatology 178 (1), 114-123, 2018
Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin
MT Fernandez‐Figueras, C Carrato, X Sáenz, L Puig, E Musulen, ...
Journal of the European Academy of Dermatology and Venereology 29 (5), 991-997, 2015
Acute febrile neutrophilic dermatosis (Sweet's syndrome)
International journal of dermatology 32 (4), 261-268, 1993
PASI 90 response: the new standard in therapeutic efficacy for psoriasis
L Puig
Journal of the European Academy of Dermatology and Venereology 29 (4), 645-648, 2015
A consensus report on appropriate treatment optimization and transitioning in the management of moderate‐to‐severe plaque psoriasis
U Mrowietz, E De Jong, K Kragballe, R Langley, A Nast, L Puig, K Reich, ...
Journal of the European Academy of Dermatology and Venereology 28 (4), 438-453, 2014
Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis
E Daudén, S Castañeda, C Suárez, J García‐Campayo, AJ Blasco, ...
Journal of the European Academy of Dermatology and Venereology 27 (11), 1387 …, 2013
Acute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin, and keratins 6 and …
DS Rosenthal, CEM Griffiths, SH Yuspa, DR Roop, JJ Voorhees
Journal of investigative dermatology 98 (3), 1992
CLINICAL AND LABORATORY INVESTIGATIONS: Pityriasis Lichenoides in Children: Clinicopathologic Review of 22 Patients
J Romaní, L Puig, MT Fernández‐Figueras, JM de Moragas
Pediatric dermatology 15 (1), 1-6, 1998
Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III …
A Kavanaugh, L Puig, AB Gottlieb, C Ritchlin, Y You, S Li, M Song, ...
Annals of the Rheumatic Diseases 75 (11), 1984-1988, 2016
Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin‐17 inhibitors and their practical management
DM Saunte, U Mrowietz, L Puig, C Zachariae
British Journal of Dermatology 177 (1), 47-62, 2017
The system can't perform the operation now. Try again later.
Articles 1–20